Occurence, etiology, and clinical significance of extreme thrombocytosis: A study of 280 cases
References (23)
Platelet millionaires
Lancet
(1980)Bleeding and thrombocytosis in the myeloproliferative disorders
Blood
(1984)- et al.
Thrombocythaemia
Clin Haematol
(1972) - et al.
Thrombocytosis and thrombocythemia
Hematol Oncol Clin North Am
(1990) - et al.
The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases
Am J Hematol
(1985) Thrombocytosis
- et al.
Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group
Semin Hematol
(1986) - et al.
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols
Semin Hematol
(1986) Kawasaki syndrome
- et al.
Case records of the Massachusetts General Hospital
N Engl J Med
(1988)
Profound thrombocytosis in a patient with iron-lack anemia
South Med J
Cited by (158)
Extreme thrombocytosis with severe anemia and infection in a Sudanese patient: A case report
2022, Annals of Medicine and SurgeryEtiologies of Extreme Thrombocytosis: A Contemporary Series
2019, Mayo Clinic ProceedingsCitation Excerpt :and (2) What should be the extent of evaluation to rule out such a possibility? These questions were not addressed by previous studies.3,4,6 In our study, the discovery of a new malignancy was relatively uncommon (∼10%) and most were in the outpatient setting with an abnormal platelet count as the isolated finding—features highly suggestive of myeloid neoplasms.
Reactive thrombocytosis in acute infectious diseases: Prevalence, characteristics and timing
2019, European Journal of Internal MedicineThrombocytosis and essential thrombocythemia
2019, PlateletsSerum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond
2018, Analytica Chimica ActaCitation Excerpt :Based on our data achieved in healthy individuals, we cannot rule out that pathological high platelet numbers may lead to the detection of differences between standard and platelet–free plasma. But it should be considered that the platelet count in extreme pathologically samples is only twice or three times higher than the upper reference range of 450,000 platelets/μl in healthy individuals [31]. Noteworthy, in our study a ten-fold difference in the platelet number between standard and platelet-free plasma samples resulted in no significant difference of the profiled plasma metabolome.
Trombocitemia esencial
2022, Gaceta Medica de Mexico